Clinical and angiographic outcomes
| Overall (n = 36) | Type I (n = 14) | Type II (n = 16) | Type III (n = 6) | P Value | |
|---|---|---|---|---|---|
| Technical success (No.) (%) | 29 (80.6) | 13 (92.9) | 13 (81.3) | 3 (50.00) | .038 |
| Periprocedural complication (No.) (%) | 7 (19.4) | 1 (7.1) | 3 (18.8) | 3 (50.00) | .038 |
| Perforation | 2 (5.6) | 0 | 0 | 2 (33.3) | .027 |
| Dissection | 2 (5.6) | 0 | 1 (6.25) | 1 (16.7) | .145 |
| Thrombosis | 1 (2.8) | 1 (7.1) | 0 | 0 | .274 |
| Reperfusion hemorrhage | 2 (5.6) | 0 | 2 (12.5) | 0 | .654 |
| Stroke within 30 days (No.) (%) | 6 (16.7) | 1 (7.1) | 2 (12.5) | 3 (50.00) | .039 |
| Ischemic stroke | 2 (5.6) | 1 (7.1) | 0 | 1 (16.7) | .654 |
| Hemorrhagic stroke | 4 (11.1) | 0 | 2 (12.50) | 2 (33.3) | .034 |
| Death within 30 days (No.) (%) | 2 (5.6) | 0 | 2 (12.5) | 0 | .654 |
| mRS score at 90 days (median) (IQR) | 1.00 (1.00–2.00) | 1.00 (0.00–2.00) | 1.00 (1.00–2.00) | 1.00 (1.00–2.00) | .218 |
| Clinical follow-up (median) (IQR) (mo) | 12.00 (6.00–24.00) | 9.00 (6.00–14.25) | 24.00 (7.50–34.50) | 9.00 (8.00–9.00) | .267 |
| Imaging follow-up (median) (IQR) (mo) | 12.00 (3.00–12.00) | 6.00 (3.00–12.00) | 12.00 (3.00–12.00) | 24.00 (6.00–24.00) | .28 |
| Stroke and death beyond 30 days (No.) (%) | 2/27 (7.40) | 1/12 (8.33) | 1/12 (8.33) | 0/3 | 1 |
| Restenosis (No.) (%) | 4/26 (15.38) | 1/11 (9.09) | 3/12 (25.00) | 0/3 | .757 |